Shareholders Meeting - EGM 10.04.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rekvina Laboratories has called an Extraordinary General Meeting on April 10, 2026 to seek shareholders' approval for multiple significant corporate actions. The biggest item is the acquisition of 100% stake in Radiant Parenterals Limited through a share swap, where Rekvina will issue 46,27,750 equity shares of face value ₹5 at ₹10 per share (aggregating ₹4.62 crore) to Radiant's existing shareholders in exchange for 18,51,100 shares of Radiant valued at ₹25 each. To facilitate this, the company is also seeking to increase its authorised share capital from ₹3.5 crore to ₹6 crore and amend its Articles of Association. Additionally, shareholders will vote on a separate preferential issue of 4,60,000 equity shares to non-promoters for cash (₹46 lakh total), Section 186 approval for investments/loans up to ₹10 crore, and related party transactions with promoter group entities and Radiant Parenterals worth up to ₹4.62 crore.
This EGM is centred on a strategic acquisition of Radiant Parenterals Limited via a share swap, which will lead to substantial equity dilution for existing shareholders (roughly 46.27 lakh new shares being issued). The deal appears to be largely promoter-driven, with promoters and promoter group receiving most of the new shares, raising related-party transaction concerns. Existing shareholders should closely evaluate the swap ratio (2.5 Rekvina shares per Radiant share) and the premium being given, as well as the use of authorised capital headroom for future fund-raising.